Pharmalex Nordic ApS: Financial statements 2021
CVR: 37541540
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Pharmalex Nordic ApS (CVR 37541540) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,352,246 and a net result of DKK 4,937,451 compared with DKK 3,603,867 the year before. That is an increase of 28.6% compared with the year before. Equity in the 2021 report amounted to DKK 33,136,382. The solvency ratio was 56.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,352,246
- Profit/Loss
- DKK 4,937,451
- Equity
- DKK 33,136,382
- Total Assets
- DKK 58,916,801
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 3.4M | 4.9M | 33.1M | 2 |
| 2020 | - | 2.6M | 3.6M | 28.2M | 2 |
| 2019 | - | 2.4M | 2.4M | 24.6M | 2 |
| 2018 | - | 1.9M | 892K | 22.2M | 1 |
| 2017 | - | 100K | 495K | 2.9M | 1 |
Official annual report
Find more companies like Pharmalex Nordic ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Pharmalex Nordic ApS has published its annual report for 2020. Gross profit came to DKK 2,607,653, and the net result was DKK 3,603,867.
About Pharmalex Nordic ApS
Pharmalex Nordic ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Åsa Pihlblad and Christopher Gauglitz. The company is owned by AmerisourceBergen International B.V.. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 3,533,803 and a net result of DKK 1,709,691 compared with DKK -88,447,652 the year before. Equity in the 2025 report amounted to DKK -45,957,544.